Annual Secretarial Compliance Report for the year ended March 31, 2025.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Globalspace Technologies has submitted its Annual Secretarial Compliance Report for FY2024-25, certifying compliance with SEBI LODR Regulations. Two non-compliances were flagged by the Practising Company Secretary. First, there was a 310-day delay in appointing a common Independent Director on the board of its material subsidiary, Innopharm Healthcare Private Limited (which became material on May 4, 2024); the director was eventually appointed on March 10, 2025. Second, the company delayed submitting the Cash Flow Statement for its consolidated financial results for Q2 FY25 (quarter ended September 30, 2024), submitted only on December 21, 2024, attracting a BSE fine of ₹1,53,400. A prior-year observation was also addressed, where material related party transactions from FY2023-24 were ratified by shareholders at the AGM on September 23, 2024. Overall, the company is largely compliant on Secretarial Standards, policies, website disclosures, insider trading, and governance matters.
The disclosure highlights two governance lapses — a delayed subsidiary board appointment and a late consolidated filing resulting in a ₹1.53 lakh BSE penalty — which may dent investor confidence on compliance discipline, though the company has since corrected the issues and strengthened internal controls.